Home › Funds › ADAR1 Capital Management, LLC › TENX

ADAR1 Capital Management, LLC position in TENX

TENAX THERAPEUTICS INC · Health Care

ADAR1 Capital Management, LLC reported holding 6,524,151 shares of TENX (TENAX THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$12.3M, representing 0.68% of its reported portfolio and ranking #38 among its reported holdings. ADAR1 Capital Management, LLC has disclosed TENX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)6.52M sh
Reported value held$12.33M
Portfolio Weight0.68%
First reportedQ3 2024
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How ADAR1 Capital Management, LLC's TENX position evolved

ADAR1 Capital Management, LLC first disclosed a stake in TENX in Q3 2024 at 62,423 shares (US$216K). The position peaked in Q3 2026 at 6,524,151 shares, worth US$12.3M. Across 9 filings, ADAR1 Capital Management, LLC increased the stake 6 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 6,524,151 shares valued at US$12.3M — an increase of 6,303,689 shares quarter over quarter.. Notable position changes include a 126% increase in Q2 2025 (shares rose 32% over the following quarter), a 235% increase in Q1 2026 (shares fell 9% over the following quarter), a 2859% increase in Q3 2026 (shares fell 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 62.42K $215.98K New
Q4 2024 34.69K $214.75K Reduce
Q1 2025 68.74K $450.25K Add
Q2 2025 155.56K $896.01K Add
Q3 2025 53.43K $406.59K Reduce
Q4 2025 63.67K $776.17K Add
Q1 2026 213.46K $3.41M Add
Q2 2026 220.46K $3.21M Add
Q3 2026 6.52M $12.33M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TENX and 13F data

TENX (TENAX THERAPEUTICS INC) is a Health Care company. 55 other funds we track also report a position in TENX — the largest reported positions include BVF INC/IL (US$4.9M), Vivo Capital, LLC (US$4.7M), Avidity Partners Management LP (US$3.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TENX

All TENX fund holders →

FAQ

How long has ADAR1 Capital Management, LLC held TENX?

ADAR1 Capital Management, LLC has disclosed TENX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is ADAR1 Capital Management, LLC's current position in TENX?

As of Q3 2026, ADAR1 Capital Management, LLC holds 6.52M shares of TENX (TENAX THERAPEUTICS INC), valued at $12.33M, representing 0.68% of its reported portfolio and ranking #38.

Has ADAR1 Capital Management, LLC been buying or selling TENX?

In the latest 13F filing (Q3 2026), ADAR1 Capital Management, LLC increased its position in TENX. The position peaked in Q3 2026 at 6.52M shares.

Which other funds hold TENX?

Other major institutional holders of TENX include BVF INC/IL, Vivo Capital, LLC, Avidity Partners Management LP, among 55 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.